Target intelligence / Profile preview

Immunoglobulin heavy variable 5-10-1 (IGHV5-10-1)

Target
IGHV5-10-1
Molecular classification
Other
01

Overview

Immunoglobulin heavy variable 5-10-1 is a variable region segment of the immunoglobulin heavy chain, which contributes to the formation of antigen-binding sites in antibodies. The variable domains are assembled by V-(D)-J gene rearrangement and further diversified by somatic hypermutations, allowing for affinity maturation. IGHV5-10-1 is predicted to enable antigen-binding activity and to be involved in humoral immunity by forming part of the immunoglobulin complexes on B lymphocytes or secreted antibodies. The query refers to "IGHVIII-5-1" and its variants, which are not standard gene symbols and appear to refer to a variant/alias form of IGHV5-10-1. There is no major evidence that "IGHVIII-5-1" is a canonical or functional therapeutic target. It is a gene segment, not a druggable target or a receptor in the classical sense; instead, it encodes part of the immunoglobulin variable domain, which contributes to antibody diversity. These segments are not targeted by therapeutic agents—instead, antibodies as a whole are therapeutic agents. There is no evidence that drugs interact specifically with this gene segment. The symbol "IGHVIII-5-1" is nonstandard, and the standard accurate form is IGHV5-10-1. There is also IGHV5-51, but this is a different gene segment. This gene segment functions as a component of antibodies and is not a therapeutic target, receptor, or enzyme itself. The request for interacting drugs, biomarkers, safety concerns, and mechanisms of action is not applicable to such germline immunoglobulin segments. "Immunoglobulin heavy variable 5-10-1" (IGHV5-10-1) is a genetic segment that codes for a portion of the antibody heavy chain variable region and is not a receptor, enzyme, or direct therapeutic target. The aliases such as "IGHVIII-5-1" are nonstandard and reflect imprecise or alternative database nomenclature.

Other names
IGHVIII-5-1IGHV(III)-5-13-05.1PIGHVIII51
02

Biological functions

Antigen bindingImmune response (immunoglobulin mediated)
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin heavy variable 5-10-1 (IGHV5-10-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 5-10-1 (IGHV5-10-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call